Evaluation reports
FR
HITh - Hemostase, inflammation, thrombose
Type: Research entity evaluation report
Evaluation campaign: 2024-2025 (group E)
- Published on: 11/02/2025
Institution(s) concerned:
Université Paris Saclay
, Institut national de la santé et de la recherche médicale - INSERM
Disciplinary research field: Life and Earth Sciences (SVE) ; SVE6 Public Health, Epidemiology, Clinical Research
Scientific field(s): 5 - Biologie, medecine et santé
ERC panel(s): LS7 Diagnostic tools, therapies and public health: aetiology, diagnosis and treatment of disease, public health, epidemiology, pharmacology, clinical medicine, regenerative medicine, medical ethics ; LS4 Physiology, Pathophysiology and Endocrinology: organ physiology, pathophysiology, endocrinology, metabolism, ageing, regeneration, tumorigenesis, cardiovascular disease, metabolic syndrome
Keywords: Hémostase ; hémocompatibilité ; médicaments antithrombotiques ; plaquettes ; progéniteurs endothéliaux